Litcius/Paper detail

Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis

Mazen Noureddin, Calum Jones, Naim Alkhouri, Eduardo Vilar‐Gómez, Douglas T. Dieterich, Mary E. Rinella, George Therapondos, Nigel Girgrah, Parvez Mantry, Norman Sussman, Viviana Figueroa Diaz, Michael Fuchs

2020Gastroenterology133 citationsDOI

Topics & Concepts

Nonalcoholic fatty liver diseaseMedicineInternal medicineHepatologyPopulationType 2 diabetesFatty liverLiver diseaseGastroenterologyDiabetes mellitusDiseaseEndocrinologyEnvironmental healthLiver Disease Diagnosis and TreatmentLiver Disease and TransplantationHepatocellular Carcinoma Treatment and Prognosis
Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis | Litcius